{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-000372","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.503551+00:00","generated_at":"2026-06-05T01:29:31.327678+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Renovaro receives termination notice for License Agreement covering HIV candidate RENB-HV-01","bullets":["Weird Science LLC terminated the License Agreement for RENB-HV-01 on March 1, 2024.","Renovaro had previously deprioritized RENB-HV-01 as costly and long-term, focusing on faster pipelines.","Lead candidate is now RENB-DC-11, a potential cancer vaccine for solid tumors; HIV programs continue under other licenses.","Company is evaluating all options regarding the termination and does not acknowledge the termination as effective."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-000372","json":"https://secwatch.observer/filing/0001731122-24-000372.json","markdown":"https://secwatch.observer/filing/0001731122-24-000372.md","text":"https://secwatch.observer/filing/0001731122-24-000372.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000372/0001731122-24-000372-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000372/e5476_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T01:29:31.327678+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"655a285d5dce29efba3a600e48d0a77c7d4dca7e","claim":"Lunai Bioworks Inc. terminated License Agreement with Weird Science LLC (effective 2024-03-01).","evidence_excerpt":"On March 1, 2024, Renovaro Inc. (the “Company”) received a notice from the sole manager of Weird Science LLC terminating the License Agreement by and between Weird Science LLC and Enochian Biopharma, Inc. (now known as Renovaro Biosciences, Inc.), a wholly-owned subsidiary of the Company, dated February 16, 2018 (the “License Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000372/0001731122-24-000372-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"Weird Science LLC"},{"label":"Effective","value":"2024-03-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}